Dow Up 0.64% Nasdaq Up 0.68%

ImmunoGen, Inc. (IMGN)

-NasdaqGS
11.34 0.04(0.35%) Sep 18, 4:00PM EDT
Prev Close:11.30
Open:11.39
Bid:10.57 x 1000
Ask:11.63 x 600
1y Target Est:15.27
Beta:1.75
Next Earnings Date:24-Oct-14IMGN Earnings announcement
Day's Range:11.17 - 11.48
52wk Range:10.28 - 18.19
Volume:384,287
Avg Vol (3m):810,362
Market Cap:974.19M
P/E (ttm):N/A
EPS (ttm):-0.78
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
IMGNUp 0.35%974.19M
PFE193.90B
RHHBY257.53B
SGEN5.08B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):16.21
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-0.72
Quarterly EPS Est (Sep-14) :-0.15
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ImmunoGen, Inc., a biotechnology company, develops targeted anticancer therapeutics. It develops its products using its antibody-drug conjugates technology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback